Roberta Cianfrocca

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Retraction Note: Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.

Retraction Note: Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: September 05, 2024

Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.

Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.

Journal: Cancer letters

Published: May 05, 2020

Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.

Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.

Journal: Communications biology

Published: February 28, 2020

Methods to Investigate β-Arrestin-1/β-Catenin Signaling in Ovarian Cancer Cells.

Methods to Investigate β-Arrestin-1/β-Catenin Signaling in Ovarian Cancer Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 29, 2019

β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.

β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.

Journal: Nature communications

Published: September 14, 2018

Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.

Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.

Journal: Expert opinion on therapeutic targets

Published: August 01, 2017

Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.

Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.

Journal: Cell death and differentiation

Published: March 20, 2017

Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.

Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.

Journal: Oncotarget

Published: December 10, 2015

Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.

Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.

Journal: Life sciences

Published: October 23, 2015

Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis.

Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis.

Journal: Life sciences

Published: October 23, 2015

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.

Journal: Oncotarget

Published: September 01, 2015

Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.

Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.

Journal: Oncogene

Published: February 11, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026